AdaptHealth Corp. reported strong third-quarter results, driven by employee dedication and strategic acquisitions, leading to increased financial guidance for fiscal year 2020.
Increased financial guidance for fiscal year 2020 for net revenue to $1.00 billion to $1.04 billion.
Adjusted EBITDA is expected to be $186 million to $194 million.
Adjusted EBITDA less Patient Equipment Capex is projected to be $124 million to $130 million.
Acquired several diabetes management and home medical equipment businesses in high-growth areas.
The company increased financial guidance for fiscal year 2020 and provided guidance for 2021.
Analyze how earnings announcements historically affect stock price performance